http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103965174-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eb25c233d984147b603aa2495a7f6daf
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12
filingDate 2013-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7eeee83b796b41344aa9413e03e7cbba
publicationDate 2014-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-103965174-A
titleOfInvention Quinazoline-based EGFR tyrosine kinase inhibitors containing a zinc-binding group
abstract The present invention belongs to the technical field of medicine, and specifically relates to a quinazoline-based EGFR tyrosine kinase inhibitor containing a zinc binding group represented by general formula (I), its deuterated product, its pharmaceutically acceptable salt or its stereoisomer body, wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , W, X, L and T are as defined in the specification; the present invention also relates to the preparation method of these compounds, containing these compounds pharmaceutical preparations, and the use of these compounds in the preparation of medicines for treating and/or preventing tumors.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113845485-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109265449-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109265449-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114685382-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113620873-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-116444447-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-116444447-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111499634-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105175400-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113845485-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105175400-A
priorityDate 2013-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102686581-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102898386-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412167557
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466591115
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465203300
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148896846
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163593949
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468283949
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466642542
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466643767
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468028227
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466587473
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467870951

Total number of triples: 44.